Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
21.28
22.46
18.93
17.28
11.65
10.32
9.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
21.28
22.46
18.93
17.28
11.65
10.32
9.07
Raw Material Cost
8.18
14.60
7.00
7.42
5.17
4.02
3.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.21
1.21
1.20
1.16
1.33
0.21
0.22
Selling and Distribution Expenses
8.85
7.92
9.62
8.52
6.72
5.29
5.59
Other Expenses
0.06
-0.01
0.25
-0.00
-0.22
0.03
0.27
Total Expenditure (Excl Depreciation)
18.81
23.63
20.34
17.10
11.02
9.82
12.01
Operating Profit (PBDIT) excl Other Income
2.5
-1.2
-1.4000000000000001
0.2
0.6
0.5
-2.9
Other Income
0.16
0.62
0.15
0.14
0.19
0.20
0.17
Operating Profit (PBDIT)
3.65
0.46
-0.25
1.33
1.18
0.99
-2.49
Interest
1.21
1.21
1.20
1.16
1.33
0.21
0.22
Exceptional Items
-0.01
-0.19
-0.06
-0.66
0.00
0.00
0.00
Gross Profit (PBDT)
13.10
7.86
11.92
9.86
6.48
6.30
5.63
Depreciation
1.02
1.01
1.00
1.01
0.35
0.28
0.28
Profit Before Tax
1.41
-1.96
-2.52
-1.50
-0.51
0.50
-2.99
Tax
-0.07
-0.03
0.07
0.07
0.09
-0.13
0.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1.48
-1.93
-2.58
-1.57
-0.60
0.63
-3.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1.48
-1.93
-2.58
-1.57
-0.60
0.63
-3.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1.48
-1.93
-2.58
-1.57
-0.60
0.63
-3.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
26.15
23.13
23.96
24.45
24.43
15.98
13.46
Earnings per share (EPS)
0.05
-0.07
-0.1
-0.06
-0.02
0.02
-0.12
Diluted Earnings per share
0.05
-0.07
-0.1
-0.06
-0.02
0.02
-0.12
Operating Profit Margin (Excl OI)
11.61%
-5.22%
-7.45%
1.07%
5.4%
4.93%
-32.35%
Gross Profit Margin
11.42%
-4.21%
-8.0%
-2.81%
-1.34%
7.56%
-29.84%
PAT Margin
6.97%
-8.58%
-13.66%
-9.1%
-5.13%
6.07%
-33.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -5.33% vs 19.05% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 178.95% vs 26.92% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 1,850.00% vs 50.00% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Eton Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
21.28
-0.19
21.47
11,300.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
21.28
-0.19
21.47
11,300.00%
Raw Material Cost
8.18
0.00
8.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.21
1.33
-0.12
-9.02%
Selling and Distribution Expenses
8.85
6.13
2.72
44.37%
Other Expenses
0.06
0.93
-0.87
-93.55%
Total Expenditure (Excl Depreciation)
18.81
16.80
2.01
11.96%
Operating Profit (PBDIT) excl Other Income
2.47
-17.00
19.47
114.53%
Other Income
0.16
0.62
-0.46
-74.19%
Operating Profit (PBDIT)
3.65
-16.38
20.03
122.28%
Interest
1.21
1.33
-0.12
-9.02%
Exceptional Items
-0.01
0.00
-0.01
Gross Profit (PBDT)
13.10
0.00
13.10
Depreciation
1.02
0.00
1.02
Profit Before Tax
1.41
-17.71
19.12
107.96%
Tax
-0.07
0.00
-0.07
Provisions and contingencies
0
0
0.00
Profit After Tax
1.48
-17.71
19.19
108.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1.48
-17.71
19.19
108.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1.48
-17.71
19.19
108.36%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
26.15
-12.17
38.32
314.87%
Earnings per share (EPS)
0.05
-0.06
0.11
183.33%
Diluted Earnings per share
0.05
-0.06
0.11
183.33%
Operating Profit Margin (Excl OI)
11.61%
0.00%
0.00
11.61%
Gross Profit Margin
11.42%
9,174.09%
0.00
-9,162.67%
PAT Margin
6.97%
0.00%
0.00
6.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2.13 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -5.33% vs 19.05% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 83.62% vs 58.90% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.15 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 178.95% vs 26.92% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 350.00% vs 73.91% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.35 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 1,850.00% vs 50.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 250.00% vs 158.82% in Dec 2024
Quarterly - Interest
Interest 0.12 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -7.69% vs 225.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.61%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
